BNGOMEDIUM SIGNALFINANCIAL10-K

BNGO showed significant operational improvement with revenue growing 324% and losses narrowing by 76%, though cash position remains critically low at $3M.

The dramatic reduction in R&D spending (-54%) and SG&A expenses (-32%) alongside strong revenue growth suggests a strategic pivot toward profitability, though this cost-cutting may impact future innovation. The company's cash runway appears severely constrained, dropping 67% to just $3M, which raises near-term funding concerns despite improved operational metrics.

Comparing 2026-03-23 vs 2025-03-31View on EDGAR →
FINANCIAL ANALYSIS

BNGO demonstrated substantial operational improvements with revenue surging 324% to $12M while dramatically reducing losses by 76% to -$26.4M through aggressive cost management, cutting R&D by 54% and SG&A by 32%. Operating cash flow losses narrowed significantly from -$68.9M to -$16.3M, and current liabilities decreased 39%, indicating better working capital management. However, the 67% decline in cash to just $3M creates a critical liquidity concern that overshadows the positive operational trends, suggesting immediate funding needs despite the improved efficiency metrics.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
+1617.8%
$298K→$5.1M

Interest expense surged 1617.8% — significant debt increase or rising rates materially impacting earnings.

Revenue
P&L
+324.2%
$2.8M→$12.0M

Strong top-line growth of 324.2% — accelerating demand or successful expansion into new markets.

Net Income
P&L
+76.4%
-$112.0M→-$26.4M

Net income grew 76.4% — bottom-line growth signals improving overall business health.

Operating Cash Flow
Cash Flow
+76.3%
-$68.9M→-$16.3M

Operating cash flow surged 76.3% — exceptional cash generation, highest quality earnings signal.

Operating Income
P&L
+67.9%
-$104.0M→-$33.3M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Cash & Equivalents
Balance Sheet
-67.4%
$9.2M→$3.0M

Cash declined 67.4% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

R&D Expense
P&L
-54.1%
$24.8M→$11.4M

R&D spending cut 54.1% — could signal cost discipline or concerning reduction in innovation investment.

Inventory
Balance Sheet
-41%
$13.3M→$7.8M

Inventory drawn down 41% — strong sell-through or deliberate destocking; watch for supply constraints.

Current Liabilities
Balance Sheet
-38.6%
$37.3M→$22.9M

Current liabilities reduced — improved short-term financial position and working capital health.

SG&A Expense
P&L
-32.2%
$51.9M→$35.1M

SG&A reduced 32.2% — improved cost efficiency or headcount reduction improving operating margins.

LANGUAGE CHANGES
NEW — 2026-03-23
PRIOR — 2025-03-31
ADDED
As of March 19, 2026, the Registrant had 11,092,000 shares of common stock, $0.0001 par value per share, outstanding.
Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause our actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements.
All statements other than statements of historical fact are statements that could be forward-looking statements.
You can identify these forward-looking statements through our use of words such as may, can, anticipate, assume, should, indicate, would, believe, contemplate, expect, seek, estimate, continue, plan, point to, project, predict, could, intend, target, will, potential and other similar words and expressions of the future.
The foregoing does not represent an exhaustive list of matters that may be covered by the forward-looking statements contained herein or risk factors that we are faced with that may cause our actual results to differ from those anticipated in such forward-looking statements.
+7 more — sign up free →
REMOVED
The foregoing reflects the reverse stock split of the registrant s common stock that became effective on January 24, 2025 and began trading on a post-split adjusted basis on January 27, 2025.
As of March 24, 2025, the Registrant had 3,007,000 shares of common stock, $0.0001 par value per share, outstanding.
All statements other than statements of historical facts contained in this Annual Report, including statements regarding our future results of operations or financial condition, business strategy and plans, and objectives of management for future operations, are forward-looking statements.
In some cases, you can identify forward-looking statements because they contain words such as anticipate, believe, contemplate, continue, could, estimate, expect, intend, may, plan, potential, predict, project, should, target, will or would or the negative of these words or other similar terms or expressions.
We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →